Trials / Completed
CompletedNCT00555191
Fructose Malabsorption in Northern Norway
Fructose Malabsorption in Northern Norway. Fructose Malabsorption and Irritable Bowel Syndrome.
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 182 (actual)
- Sponsor
- University Hospital of North Norway · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Different published studies has shown a possible co-variation between leakage of fructose to the great bowel and exacerbation of irritable bowel syndrome (IBS) symptoms. The aim of the FINN trial is to study the role of fructose malabsorption in patients with IBS in order to evaluate different diagnostic criteria for fructose malabsorption and at the same time study the effect of diet treatment in this cohort of patients and estimate the prevalence of fructose malabsorption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | diet restriction | each meal should contain less than 2 gm fructose |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2007-11-08
- Last updated
- 2016-05-24
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00555191. Inclusion in this directory is not an endorsement.